Ocular Melanoma — Trials

Ocular Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 6
Growth YoY: —
Industry share: 35%
Top sponsor: IDEAYA Biosciences
Termination share: 31.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (36)

clinicaltrialsPublishedShowing 101–112 of 112 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00032045	Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma	completed	Phase 2	—	National Cancer Institute (NCI)NIH	1	Jun 20, 2013	clinicaltrials
NCT00058279	Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma	completed	Phase 1 / Phase 2	—	National Cancer Institute (NCI)NIH	1	Jun 20, 2013	clinicaltrials